3 Jan 2024 • Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

• In a study on glucocorticoid (GC) bridging therapy in rheumatoid arthritis patients, those with GC bridging showed faster clinical improvement within the first 6 months & fewer changes in disease-modifying antirheumatic drugs.
• Excluding the period of bridging, later GC use was low in both groups and cumulative doses were similar.
• As anticipated, overall GC use was higher in the bridgers at 12 months.

These findings highlights the benefits of GC bridging in RA, focusing on rapid early improvement & reduced subsequent DMARD adjustments.

Source: Annals of the Rheumatic Diseases | Read full story